Genomics
NanoCellect raises $35M for new development
NanoCellect Biomedical has raised $35 million this year in funding rounds to accelerate the company's commercial growth plans and new product development goals. Read More
Beckman debuts Emnetik system for plasma prep and PCR cleanup
Beckman Coulter Life Sciences has launched the Emnetik system, which simplifies plasmid preparation and polymerase chain reaction (PCR) cleanup. The system consists of the Emnetik 24 benchtop device and accompanying PCR cleanup and plasmid purification kits. Read More
New software finds relationships between RNA modifications, cancers
A new computational tool called ModTect could identify RNA modifications using preexisting sequencing data gathered from clinical cohort studies. The tool may bring scientists closer to understanding the relationships between RNA modifications and the development of cancer and other diseases, according to a recent study in Science Advances. Read More
New gene therapy platform shows potential against certain muscle diseases
Scientists have engineered a new family of adeno-associated viruses (AAVs) to deliver therapeutic genes to muscle tissue at 100 to 250 times lower doses than previous AAV vectors, potentially reducing the risk of liver damage and other serious side effects, according to a new study published in Cell on September 9. Read More
How challenging risky ideas fuels the research ecosystem
If you knew that an experiment would fail, would it be worthwhile to conduct if it had the potential to challenge fundamental hypotheses about science? In a recent interview with ScienceBoard.net, world-renowned Stanford University scientist and serial entrepreneur Stephen Quake, PhD, discussed the value of basic research and his contributions to the biomedical field. Read More
KromaTiD launches mapping service for human genome in single cells
KromaTiD has launched a new product called dGH Screen for mapping the human genome in single cells. The tool uses the company's proprietary directional genomic hybridization (dGH) technology, a platform for measuring genomic structure and structural variation. Read More
'Dimmable' switch for gene therapy shows potential for rare diseases
A new alternative splicing system called Xon can modulate levels of protein expression in gene therapy, much like a dimmer switch. The invention addresses a major shortcoming of most gene therapies, which is the ability to regulate gene expression levels in diseases like spinal muscular atrophy. Read More
Vizgen begins shipping Merscope instruments for single-cell genomics
Vizgen has shipped its first commercial Merscope instruments to research institutions as part of a limited summer release program. Merscope enables high-plex, single-cell spatial genomics and large-scale spatial profiling of individual transcripts within cells. Read More
Next-generation gene therapy points to base editing
Base editing has emerged as a new player in the gene therapy arena, with rapid advances in technology and evidence of proof of concept in rare genetic disease and beyond. Read More
Cell and gene therapy firms see over $13.6B so far in 2021
Rapid financing activity in the cell and gene therapy industry has exceeded $13 billion in 2021. Over half of this funding is from venture capital and private investments, with over 100 funding deals of this type. Read More
Conferences
Bio-IT World Conference and Expo
September 20-22
Boston, Massachusetts United States
BioProcess International
September 20-23
Boston, Massachusetts United States
Cell and Gene Therapy Manufacturing and Commercialization
September 20-23
Boston, Massachusetts United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter